Apyx Medical (APYX) Competitors $2.09 +0.03 (+1.46%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$2.09 0.00 (0.00%) As of 08/22/2025 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock APYX vs. NPCE, DRTS, TCMD, SKIN, CATX, SMTI, NNOX, BWAY, OM, and STIMShould you be buying Apyx Medical stock or one of its competitors? The main competitors of Apyx Medical include NeuroPace (NPCE), Alpha Tau Medical (DRTS), Tactile Systems Technology (TCMD), Beauty Health (SKIN), Perspective Therapeutics (CATX), Sanara MedTech (SMTI), Nano-X Imaging (NNOX), Brainsway (BWAY), Outset Medical (OM), and Neuronetics (STIM). These companies are all part of the "medical equipment" industry. Apyx Medical vs. Its Competitors NeuroPace Alpha Tau Medical Tactile Systems Technology Beauty Health Perspective Therapeutics Sanara MedTech Nano-X Imaging Brainsway Outset Medical Neuronetics NeuroPace (NASDAQ:NPCE) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations. Which has more volatility & risk, NPCE or APYX? NeuroPace has a beta of 1.89, suggesting that its stock price is 89% more volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Is NPCE or APYX more profitable? NeuroPace has a net margin of -29.29% compared to Apyx Medical's net margin of -37.11%. Apyx Medical's return on equity of -158.22% beat NeuroPace's return on equity.Company Net Margins Return on Equity Return on Assets NeuroPace-29.29% -168.61% -25.48% Apyx Medical -37.11%-158.22%-28.30% Do analysts rate NPCE or APYX? NeuroPace presently has a consensus price target of $16.60, indicating a potential upside of 84.65%. Given NeuroPace's stronger consensus rating and higher probable upside, analysts plainly believe NeuroPace is more favorable than Apyx Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroPace 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67 Which has better earnings & valuation, NPCE or APYX? Apyx Medical has lower revenue, but higher earnings than NeuroPace. NeuroPace is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroPace$79.91M3.72-$27.14M-$0.84-10.70Apyx Medical$48.10M1.64-$23.46M-$0.45-4.64 Do insiders and institutionals believe in NPCE or APYX? 78.8% of NeuroPace shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 20.5% of NeuroPace shares are held by insiders. Comparatively, 15.2% of Apyx Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media prefer NPCE or APYX? In the previous week, NeuroPace had 7 more articles in the media than Apyx Medical. MarketBeat recorded 7 mentions for NeuroPace and 0 mentions for Apyx Medical. NeuroPace's average media sentiment score of 0.85 beat Apyx Medical's score of 0.37 indicating that NeuroPace is being referred to more favorably in the media. Company Overall Sentiment NeuroPace Positive Apyx Medical Neutral SummaryNeuroPace beats Apyx Medical on 12 of the 17 factors compared between the two stocks. Get Apyx Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APYX vs. The Competition Export to ExcelMetricApyx MedicalMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$79.04M$11.00B$5.81B$9.76BDividend YieldN/A1.85%4.39%4.06%P/E Ratio-4.6422.3931.3626.05Price / Sales1.6430.27387.8788.42Price / CashN/A25.2938.0259.36Price / Book10.453.519.536.60Net Income-$23.46M$211.77M$3.26B$265.65M7 Day Performance-3.24%4.44%2.14%2.00%1 Month Performance-11.81%10.21%3.22%0.46%1 Year Performance60.77%-9.01%30.18%18.88% Apyx Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APYXApyx Medical1.6269 of 5 stars$2.09+1.5%N/A+59.5%$79.04M$48.10M-4.64270Gap UpNPCENeuroPace3.3453 of 5 stars$8.42-1.6%$16.60+97.1%+13.5%$283.18M$79.91M-10.02170Short Interest ↑DRTSAlpha Tau Medical2.6604 of 5 stars$3.26-0.6%$9.00+176.1%+43.6%$278.21MN/A-6.7980News CoverageTCMDTactile Systems Technology2.4604 of 5 stars$12.58+1.4%$13.50+7.3%+1.4%$276.64M$298.85M20.291,037Positive NewsSKINBeauty Health0.9993 of 5 stars$2.19+0.5%$2.63+19.9%+27.7%$276.48M$334.30M-7.821,030Positive NewsCATXPerspective Therapeutics1.5396 of 5 stars$3.69+2.2%$12.56+240.3%-76.6%$268.09MN/A0.0070Analyst RevisionSMTISanara MedTech2.0582 of 5 stars$31.58+6.4%$50.00+58.3%-2.4%$264.22M$86.67M-27.2260News CoverageAnalyst RevisionNNOXNano-X Imaging2.0831 of 5 stars$4.26-3.6%$8.50+99.5%-42.3%$255.38M$11.28M-4.73190BWAYBrainsway3.1478 of 5 stars$14.85+14.4%$18.00+21.2%+89.5%$245.33M$41.02M57.12120News CoverageShort Interest ↓High Trading VolumeOMOutset Medical1.4881 of 5 stars$13.67+2.9%$24.67+80.4%+33.6%$236.11M$113.69M-0.67520Analyst ForecastSTIMNeuronetics1.5617 of 5 stars$3.54+6.0%$7.00+97.7%+252.3%$234.08M$111.11M-3.13180Positive NewsGap Up Related Companies and Tools Related Companies NPCE Competitors DRTS Competitors TCMD Competitors SKIN Competitors CATX Competitors SMTI Competitors NNOX Competitors BWAY Competitors OM Competitors STIM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APYX) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Apyx Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access